Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2010 | Version v1.0.0
Journal Article Open

Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia

Abstract

Serious bleeding and thrombotic complications are frequent in acute promyelocytic leukemia (APL) and are major causes of morbidity and mortality. Microparticles (MP) have been used to study the risk and pathogenesis of thrombosis in many malignant disorders. To date, from published articles, this approach had not been applied to APL. In this article, the hemostatic dysfunction in this disorder is briefly reviewed. A study design to address this problem using MP is described. MP bearing tissue factor, profibrinolytic factors (tissue plasminogen activator and annexin A2), and the antifi-brinolytic factor plasminogen activator inhibitor type 1 were measured using flow cytometry. The cellular origin of the MP was identified by specific cell surface markers. Comparison of the various populations of MP was made between samples collected at the time of diagnosis with those collected at molecular remission. Preliminary data suggest that this approach is feasible.

Other

original_citation: Kwaan, H. C., & Rego, E. M. (2010). Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Semin Thromb Hemost, 36(8), 917-924. doi:10.1055/s-0030-1267045

Files

MP_APL_kwaan_rego.pdf
Files (135.3 kB)
Name Size Download all
md5:ef4f5521303066f77b1d0c57b8f56b0b
135.3 kB Preview Download

Additional details

Created:
March 30, 2023
Modified:
March 30, 2023